SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-04-005850
Filing Date
2004-10-22
Accepted
2004-10-22 11:17:02
Documents
1
Period of Report
2003-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 3945
  Complete submission text file 0001140361-04-005850.txt   5900
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1691 MICHIGAN MIAMI FL 33139
Business Address 305-534-3383
Davenport Gregory (Reporting) CIK: 0001304500 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-16929 | Film No.: 041091016